{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:47:01Z","timestamp":1757310421448},"reference-count":112,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1053\/ejso.2002.1319","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T14:20:15Z","timestamp":1042122015000},"page":"692-700","source":"Crossref","is-referenced-by-count":13,"title":["New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma"],"prefix":"10.1053","volume":"28","author":[{"given":"D.C.P.","family":"Cobben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Koopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.M.G.","family":"Tiebosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.L.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.","family":"Elsinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Wobbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ejso.2002.1319_RF1","unstructured":"Visser, O, Coebergh, JWW, Schouten, LJM, Dijck van, JAAM, Incidence of cancer in the Netherlands 1997; Ninth report of the Netherlands cancer registry, Dutch Cancer Registry, 2001"},{"key":"10.1053\/ejso.2002.1319_RF2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnci\/93.9.678","article-title":"Recent trends in cutaneous melanoma incidence among whites in the United States","volume":"93","author":"Jemal","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ejso.2002.1319_RF3","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jama.281.7.640","article-title":"Is physician detection associated with thinner melanomas?","volume":"281","author":"Epstein","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/ejso.2002.1319_RF5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/ejso.1998.0634","article-title":"The effect of surgical wounding on tumour development","volume":"25","author":"Hofer","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM198805053181804","article-title":"Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3cm","volume":"318","author":"Veronesi","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/ejso.2002.1319_RF7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000658-199309000-00005","article-title":"Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4mm). Results of a multi-institutional randomized surgical trial","volume":"218","author":"Balch","year":"1993","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1319_RF8","first-page":"101","article-title":"Long-term results of a prospective surgical trial comparing 2cm vs. 4cm excision margins for 740 patients with 1\u20134mm melanomas","volume":"8","author":"Balch","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jama.1992.03490030026014","volume":"268","year":"1992","journal-title":"JAMA"},{"key":"10.1053\/ejso.2002.1319_RF10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0748-7983(97)93237-6","article-title":"Principles and guidelines for surgeons: management of cutaneous malignant melanoma. European Society of Surgical Oncology Brussels","volume":"23","author":"Kroon","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<272::AID-SSU2>3.0.CO;2-#","article-title":"Margin of resection in the management of primary melanoma","volume":"14","author":"Cascinelli","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF12","unstructured":"Randomised trial of width of excision of thick cutaneuous melanoma, Melanoma Study Group (MSG)\/British Association of Plastic Surgeons, 2001"},{"key":"10.1053\/ejso.2002.1319_RF13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM197709222971202","article-title":"Inefficacy of immediate node dissection in stage I melanoma of the limbs","volume":"297","author":"Veronesi","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1053\/ejso.2002.1319_RF14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z","article-title":"A pros-pective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results","volume":"41","author":"Sim","year":"1978","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","article-title":"Efficacy of an elective regional lymph node dissection of 1 to 4mm thick melanomas for patients 60 years of age and younger","volume":"224","author":"Balch","year":"1996","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1319_RF16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","article-title":"Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Program","volume":"351","author":"Cascinelli","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/ejso.2002.1319_RF17","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1200\/JCO.1998.16.9.2906","volume":"16","author":"Schraffordt Koops","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF18","unstructured":"Steinmann, G, Eggermont, AM, Boehringer Ingelheim trial 152.70. An open randomised, prospective trial to compare the efficacy and safety of TNF-alfa and melphalan with melphalan alone via isolated limb perfusion for metastatic melanoma of the limb (stage IIA, IIB, IIIA and IIIAB), Boehringer Ingelheim trial 152 70, 1999"},{"key":"10.1053\/ejso.2002.1319_RF19","unstructured":"Fraker, DL, NCI-trial: Phase III randomized study of hyperthermic isolated limb perfusion and melphalan with or without tumor necrosis factor in patients with localized, advanced, extremity melanoma, ACOSOG-Z0020, 2001"},{"key":"10.1053\/ejso.2002.1319_RF20","first-page":"87","article-title":"Results of hyperthermic isolated regional perfusion of locally metastasized melanoma of the lower extremity with melphalan with or without dactinomycin using different dosage methods","volume":"2","author":"Baas","year":"1989","journal-title":"Reg Cancer Treat"},{"key":"10.1053\/ejso.2002.1319_RF21","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.1991.9.12.2091","article-title":"Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group","volume":"9","author":"Hafstrom","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/1097-0142(19930815)72:4<1224::AID-CNCR2820720415>3.0.CO;2-B","article-title":"Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment","volume":"72","author":"Hoekstra","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF23","unstructured":"Brady, MS, NCI-trial, 2001"},{"key":"10.1053\/ejso.2002.1319_RF24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10434-999-0012-9","article-title":"Will the true sentinel node please stand?","volume":"6","author":"Morton","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002590050360","article-title":"Sentinel lymph node detection and imaging","volume":"26","author":"Keshtgar","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10434-001-0538-y","article-title":"The definition of a sentinel node","volume":"8","author":"Nieweg","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF27","first-page":"147","article-title":"Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning","volume":"28","author":"Robinson","year":"1977","journal-title":"Surg Forum"},{"key":"10.1053\/ejso.2002.1319_RF28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1053\/ejso.2002.1319_RF29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02303799","article-title":"Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye","volume":"4","author":"Kapteijn","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/1097-0142(20001015)89:8<1720::AID-CNCR11>3.0.CO;2-F","article-title":"Frozen section analysis of sentinel lymph nodes in melanoma patients","volume":"89","author":"Koopal","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000658-199910000-00001","article-title":"Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group","volume":"230","author":"Morton","year":"1999","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1319_RF32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10434-001-0222-2","article-title":"Frozen section investigation of the sentinel node in malignant melanoma and breast cancer","volume":"8","author":"Tanis","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000637-199201000-00010","article-title":"Lymphoscintigraphy in malignant melanoma","volume":"28","author":"Berman","year":"1992","journal-title":"Ann Plast Surg"},{"key":"10.1053\/ejso.2002.1319_RF34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000658-199602000-00016","article-title":"Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma","volume":"223","author":"Albertini","year":"1996","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1319_RF35","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1055-3207(18)30610-0","article-title":"Management of early-stage melanoma by intra-operative lymphatic mapping and selective lymphadenectomy or \u2018watch and see\u2019","author":"Morton","year":"1992","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1053\/ejso.2002.1319_RF37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-199412000-00009","article-title":"The orderly progression of melanoma nodal metastases","volume":"220","author":"Reintgen","year":"1994","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1319_RF38","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1200\/JCO.1998.16.6.2253","article-title":"Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma","volume":"16","author":"Gershenwald","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF39","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D","article-title":"A new American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"88","author":"Balch","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF40","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF41","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF42","first-page":"188","article-title":"Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma","volume":"84","author":"Reintgen","year":"1997","journal-title":"J Fla Med Assoc"},{"key":"10.1053\/ejso.2002.1319_RF43","first-page":"964","article-title":"Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back","volume":"37","author":"Uren","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-9610(91)90255-C","article-title":"Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma","volume":"162","author":"Norman","year":"1991","journal-title":"Am J Surg"},{"key":"10.1053\/ejso.2002.1319_RF45","first-page":"1435","article-title":"Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node","volume":"34","author":"Uren","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00003072-199503000-00013","article-title":"Lymphatic drainage from peri-umbilical skin to internal mammary nodes","volume":"20","author":"Uren","year":"1995","journal-title":"Clin Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10434-999-0785-x","article-title":"Sentinel node biopsy before and after wide excision of the primary melanoma","volume":"6","author":"Karakousis","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10434-001-0192-4","article-title":"Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?","volume":"8","author":"McMasters","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF49","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archsurg.135.10.1168","article-title":"Interval nodes: the forgotten sentinel nodes in patients with melanoma","volume":"135","author":"Uren","year":"2000","journal-title":"Arch Surg"},{"key":"10.1053\/ejso.2002.1319_RF50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10434-001-0444-3","article-title":"Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma","volume":"8","author":"Thelmo","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF51","article-title":"NCI trial: Multicenter Selective Lymphadenectomy Trial","author":"Morton","year":"2001","journal-title":"NCI grant PO1 CA 29605"},{"key":"10.1053\/ejso.2002.1319_RF52","article-title":"Sunbelt Melanoma Trial: a multicenter trial of adjuvant interferon alfa-2b for melanoma in patients with early lymph node metastasis detected by lymphatic mapping and sentinel lymph node biopsy","author":"McMasters","year":"1996","journal-title":"Sunbelt Melanoma Trial (SMT)"},{"key":"10.1053\/ejso.2002.1319_RF53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bmj.321.7252.3","article-title":"The argument against sentinel node biopsy for malignant melanoma","volume":"321","author":"Thomas","year":"2000","journal-title":"BMJ"},{"key":"10.1053\/ejso.2002.1319_RF54","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2001.19.11.2851","article-title":"Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement","volume":"19","author":"McMasters","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF55","unstructured":"Eggermont, AMM, Kleeberg, UR, Ruiter, DJ, Suciu, S, European Organization for Research and Treatment of Cancer Melanoma Group trial experience with more than 2000 patients, evaluating adjuvant treatment with low or intermediate doses of interferon alpha-2b, ASCO Conference, 2001"},{"key":"10.1053\/ejso.2002.1319_RF56","unstructured":"Kirkwood, JM, Adjuvant therapy of high-risk resected melanoma: relapse-free and overall survival effects of high dose interferon alpha-2b in randomized controlled multicenter trials E1684 and E2696 and intergroup trials E1690 and E1694, ASCO Conference, 2001"},{"key":"10.1053\/ejso.2002.1319_RF57","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2001.19.9.2370","article-title":"High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH\/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694\/S9512\/C509801","volume":"19","author":"Kirkwood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF58","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(01)06068-8","article-title":"Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial","volume":"358","author":"Cascinelli","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/ejso.2002.1319_RF59","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000658-199805000-00017","article-title":"Effectiveness of positron emission tomography for the detection of melanoma metastases","volume":"227","author":"Holder","year":"1998","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1319_RF60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/PL00006666","article-title":"Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma","volume":"27","author":"Eigtved","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF61","first-page":"670","article-title":"A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection","volume":"21","author":"Som","year":"1980","journal-title":"J Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF62","first-page":"1420","article-title":"Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma","volume":"34","author":"Gritters","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00008390-199608000-00008","article-title":"Positron emission tomography in the detection and management of metastatic melanoma","volume":"6","author":"Damian","year":"1996","journal-title":"Melanoma Res"},{"key":"10.1053\/ejso.2002.1319_RF64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9098(199703)64:3<181::AID-JSO2>3.0.CO;2-6","article-title":"Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma","volume":"64","author":"Wagner","year":"1997","journal-title":"J Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF65","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1664::AID-CNCR11>3.0.CO;2-2","article-title":"Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients","volume":"82","author":"Rinne","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF66","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.1999.17.5.1508","article-title":"Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy","volume":"17","author":"Wagner","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF67","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.1998.16.5.1770","article-title":"Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma","volume":"16","author":"Macfarlane","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF68","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2001.19.10.2674","article-title":"Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma","volume":"19","author":"Acland","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.1102","article-title":"FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume","volume":"77","author":"Wagner","year":"2001","journal-title":"J Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF70","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/1097-0142(20000901)89:5<1019::AID-CNCR11>3.0.CO;2-0","article-title":"Positron emission tomography scanning in malignant melanoma","volume":"89","author":"Tyler","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF71","first-page":"153","article-title":"A review of the literature for whole-body FDG PET in the management of patients with melanoma","volume":"44","author":"Schwimmer","year":"2000","journal-title":"Q J Nucl Med"},{"key":"10.1053\/ejso.2002.1319_RF72","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/1097-0142(20010415)91:8<1530::AID-CNCR1162>3.0.CO;2-#","article-title":"Systematic review of the diagnostic accuracy of (18)F-fluoro-deoxyglucose positron emission tomography in melanoma patients","volume":"91","author":"Mijnhout","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF73","first-page":"102","article-title":"Pathological evaluation of the regional lymph nodes in malignant melanoma","volume":"10","author":"Robert","year":"1993","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/ejso.2002.1319_RF74","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.1999.17.10.3238","article-title":"Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase\u2013polymerase chain reaction in early-stage melanoma patients","volume":"17","author":"Bostick","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF75","first-page":"3","article-title":"Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction","volume":"35","author":"Jung","year":"1997","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1053\/ejso.2002.1319_RF76","first-page":"2203","article-title":"Comparison of S100 protein and MIA protein as serum marker for malignant melanoma","volume":"20","author":"Djukanovic","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1053\/ejso.2002.1319_RF77","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1200\/JCO.2001.19.4.1176","article-title":"Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I\u2013III melanoma","volume":"19","author":"Kelley","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF78","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/jcp.51.8.597","article-title":"Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients","volume":"51","author":"Hatta","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.1053\/ejso.2002.1319_RF79","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-198808000-00002","article-title":"Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study","volume":"12","author":"Cochran","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/ejso.2002.1319_RF80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ajcp\/102.1.102","article-title":"Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immuno-histochemical study with literature review","volume":"102","author":"Bautista","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/ejso.2002.1319_RF81","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jcp.54.3.196","article-title":"The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A)","volume":"54","author":"Clarkson","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1053\/ejso.2002.1319_RF82","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00000658-199412000-00010","article-title":"Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma","volume":"220","author":"Wang","year":"1994","journal-title":"Ann Surg"},{"key":"10.1053\/ejso.2002.1319_RF83","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/107327489500200504","article-title":"Accurate nodal staging of malignant melanoma","volume":"2","author":"Reintgen","year":"1995","journal-title":"Cancer Control"},{"key":"10.1053\/ejso.2002.1319_RF84","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00000478-199907000-00011","article-title":"Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micro-metastatic disease in the lymph node basin","volume":"23","author":"Blaheta","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/ejso.2002.1319_RF85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-642-59537-0_14","article-title":"Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma","volume":"158","author":"Blaheta","year":"2001","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/ejso.2002.1319_RF86","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1200\/JCO.2001.19.5.1437","article-title":"Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay","volume":"19","author":"Palmieri","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1072-7515(98)00138-0","article-title":"Minimally invasive staging of patients with melanoma: sentinel lymphaden-ectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction","volume":"187","author":"Goydos","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.1053\/ejso.2002.1319_RF88","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.280.16.1410","article-title":"Molecular staging of malignant melanoma: correlation with clinical outcome","volume":"280","author":"Shivers","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/ejso.2002.1319_RF89","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1073\/pnas.86.8.2617","article-title":"Illegitimate transcription: transcription of any gene in any cell type","volume":"86","author":"Chelly","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/ejso.2002.1319_RF90","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1600-0749.1993.tb00622.x","article-title":"Tyrosinase gene expression in human tissues","volume":"6","author":"Battyani","year":"1993","journal-title":"Pigment Cell Res"},{"key":"10.1053\/ejso.2002.1319_RF91","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10434-999-0225-y","article-title":"Molecular staging of melanoma","volume":"6","author":"Shivers","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF92","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1054\/bjoc.2000.1282","article-title":"Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes","volume":"83","author":"Calogero","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1319_RF93","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bjc.1997.597","article-title":"Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage","volume":"76","author":"Brouwenstijn","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1319_RF94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-1119(94)00522-T","article-title":"Diagnosis of micrometastases by the amplification of tissue-specific genes","volume":"159","author":"Neumaier","year":"1995","journal-title":"Gene"},{"key":"10.1053\/ejso.2002.1319_RF95","first-page":"213","article-title":"Detection of cytokeratin-19 transcripts by reverse transcriptase\u2013polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients","volume":"77","author":"Dingemans","year":"1997","journal-title":"Lab Invest"},{"key":"10.1053\/ejso.2002.1319_RF96","first-page":"3223","article-title":"Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions","volume":"57","author":"de Vries","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2002.1319_RF97","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ijc.2910630313","article-title":"Expression of MAGE genes in primary and metastatic cutaneous melanoma","volume":"63","author":"Brasseur","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1053\/ejso.2002.1319_RF98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1097-0142(20000701)89:1<97::AID-CNCR14>3.0.CO;2-0","article-title":"c-MYC and nodular malignant melanoma. A case report","volume":"89","author":"Greulich","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/ejso.2002.1319_RF99","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1054\/bjoc.1999.1055","article-title":"Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization","volume":"82","author":"Hipfel","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1053\/ejso.2002.1319_RF100","first-page":"6008","article-title":"The transcriptional repressor of p16\/Ink4a, Id1, is up-regulated in early melanomas","volume":"61","author":"Polsky","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2002.1319_RF101","first-page":"759","article-title":"Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients","volume":"149","author":"van der Velde-Zimmerman","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/ejso.2002.1319_RF102","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2001.19.3.824","article-title":"Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma","volume":"19","author":"Martenson","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF103","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.1999.17.1.304","article-title":"Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group","volume":"17","author":"Palmieri","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF104","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-642-59537-0_9","article-title":"Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients","volume":"158","author":"Schittek","year":"2001","journal-title":"Recent Results Cancer Res"},{"key":"10.1053\/ejso.2002.1319_RF105","first-page":"3619","article-title":"Tumour microdissemination and survival in metastatic melanoma","volume":"20","author":"Schrader","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1053\/ejso.2002.1319_RF106","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008390-200008000-00007","article-title":"Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells","volume":"10","author":"Schrader","year":"2000","journal-title":"Melanoma Res"},{"key":"10.1053\/ejso.2002.1319_RF107","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1200\/JCO.1999.17.8.2562","article-title":"MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases","volume":"17","author":"Curry","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2002.1319_RF108","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<291::AID-SSU5>3.0.CO;2-Y","article-title":"Therapeutic node dissections in malignant melanoma","volume":"14","author":"Karakousis","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF109","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<311::AID-SSU7>3.0.CO;2-5","article-title":"Surgery for metastatic melanoma","volume":"14","author":"Sharpless","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10434-001-0091-8","article-title":"Establishing a standard of care for the patient with melanoma","volume":"8","author":"Reintgen","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/ejso.2002.1319_RF111","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1055-3207(18)30407-1","article-title":"Melanoma nodal metastases: biologic significance and therapeutic considerations","volume":"5","author":"Reintgen","year":"1996","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1053\/ejso.2002.1319_RF112","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10434-999-0232-z","article-title":"Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes","volume":"6","author":"Bieligk","year":"1999","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798302913193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798302913193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T12:50:56Z","timestamp":1583931056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798302913193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":112,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0748798302913193"],"URL":"https:\/\/doi.org\/10.1053\/ejso.2002.1319","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}